Amneal Pharmaceuticals (AMRX) Notes Payables (2018 - 2024)

Amneal Pharmaceuticals' Notes Payables history runs 5 years deep, the most recent figure standing at $41.9 million for Q1 2024.

• In Q1 2024, Notes Payables changed N/A year-over-year to $41.9 million; the TTM figure through Mar 2024 stood at $41.9 million (changed N/A YoY), while the FY2023 annual figure was $41.4 million, up 4.38% from the prior year.
• Notes Payables was $41.9 million for Q1 2024 at Amneal Pharmaceuticals, up from $41.4 million in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $41.9 million in Q1 2024 to a low of $1.0 million in Q1 2020.
• Historically, Notes Payables has averaged $23.2 million across 4 years, with a median of $39.7 million in 2022.
• Biggest YoY gain for Notes Payables was 4.38% in 2023; the steepest drop was 4.38% in 2023.
• A 4-year view of Notes Payables shows it stood at $1.0 million in 2020, then jumped by 3870.6% to $39.7 million in 2022, then increased by 4.38% to $41.4 million in 2023, then grew by 1.08% to $41.9 million in 2024.
• The last three Notes Payables figures came in at $41.9 million (Q1 2024), $41.4 million (Q4 2023), and $41.0 million (Q3 2023), per Business Quant data.